Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes

J Cell Physiol. 2012 Sep;227(9):3201-7. doi: 10.1002/jcp.24008.

Abstract

Adenosine A(1) receptor (A(1)R)-induced translocation of PKCε to transverse (t) tubular membranes in isolated rat cardiomyocytes is associated with a reduction in β(1)-adrenergic-stimulated contractile function. The PKCε-mediated activation of protein kinase D (PKD) by endothelin-1 is inhibited by β(1)-adrenergic stimulated protein kinase A (PKA) suggesting a similar mechanism of A(1)R signal transduction modulation by adrenergic agonists may exist in the heart. We have investigated the influence of β(1)-adrenergic stimulation on PKCε translocation elicited by A(1)R. Immunofluorescence imaging and Western blotting with PKCε and β-COP antibodies were used to quantify the co-localization of PKCε and t-tubular structures in isolated rat cardiomyocytes. The A(1)R agonist CCPA increased the co-localization of PKCε and t-tubules as detected by imaging. The β(1)-adrenergic receptor agonist isoproterenol (ISO) inhibited this effect of CCPA. Forskolin, a potent activator of PKA, mimicked, and H89, a pharmacological PKA inhibitor, and PKI, a membrane-permeable PKA peptide PKA inhibitor, attenuated the negative effect of ISO on the A(1)R-mediated PKCε translocation. Western blotting with isolated intact hearts revealed an increase in PKCε/β-COP co-localization induced by A(1)R. This increase was attenuated by the A(1)R antagonist DPCPX and ISO. The ISO-induced attenuation was reversed by H89. It is concluded that adrenergic stimulation inhibits A(1)R-induced PKCε translocation to the PKCε anchor site RACK2 constituent of a coatomer containing β-COP and associated with the t-tubular structures of the heart. In that this translocation has been previously associated with the antiadrenergic property of A(1)R, it is apparent that the interactive effects of adenosine and β(1)-adrenergic agonists on function are complex in the heart.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / metabolism*
  • Adenosine / pharmacology
  • Adenosine A1 Receptor Antagonists / pharmacology
  • Adrenergic beta-1 Receptor Agonists / pharmacology
  • Animals
  • Colforsin / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Intracellular Signaling Peptides and Proteins / pharmacology
  • Isoproterenol / administration & dosage
  • Isoquinolines / pharmacology
  • Membrane Proteins / metabolism
  • Myocardium / metabolism*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism*
  • Organ Culture Techniques
  • Protein Kinase C-epsilon / genetics
  • Protein Kinase C-epsilon / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Transport / drug effects
  • Protein Transport / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Adenosine A1 / genetics
  • Receptor, Adenosine A1 / metabolism*
  • Receptors, Adrenergic, beta-1 / genetics
  • Receptors, Adrenergic, beta-1 / metabolism*
  • Signal Transduction
  • Sulfonamides / pharmacology
  • Xanthines / pharmacology

Substances

  • Adenosine A1 Receptor Antagonists
  • Adrenergic beta-1 Receptor Agonists
  • Copb1 protein, rat
  • Intracellular Signaling Peptides and Proteins
  • Isoquinolines
  • Membrane Proteins
  • Protein Kinase Inhibitors
  • Receptor, Adenosine A1
  • Receptors, Adrenergic, beta-1
  • Sulfonamides
  • Xanthines
  • protein kinase modulator
  • Colforsin
  • 2-chloro-N(6)cyclopentyladenosine
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C-epsilon
  • Adenosine
  • Isoproterenol
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide